EAPH (Easton Pharmaceuticals) Total Equity : $6.65 Mil (As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Total Equity?

Easton Pharmaceuticals's total equity for the quarter that ended in Sep. 2021 was $6.65 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Easton Pharmaceuticals Total Equity Historical Data

The historical data trend for Easton Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Total Equity Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

Total Equity

Get a 7-Day Free Trial

-0.10

0.13

7.14

7.10

6.91

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
Total Equity	Get a 7-Day Free Trial															7.10	6.91	6.81	6.73	6.65

Easton Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Easton Pharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2020 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2020 )	-	Total Liabilities(Q: Dec. 2020 )
	=	10.192	-	3.283
	=	6.91

Easton Pharmaceuticals's Total Equity for the quarter that ended in Sep. 2021 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2021 )	-	Total Liabilities(Q: Sep. 2021 )
	=	9.968	-	3.32
	=	6.65

Easton Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.